Position in LLY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$4,557,834
+$1,890,501 QoQ
Shares Held
3,800
+31.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.66%
of 13F equity value
Holder Rank
#1,789
of 4,605 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mitsubishi UFJ Asset Management (UK) Ltd. holds $5,947,574 across 2 Drug Manufacturers - General names. LLY ranks #1 (76.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
3,800 | $4,557,834 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
11,000 | $1,389,740 |
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,557,834 | 3,800 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $2,667,333 | 2,900 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $2,794,168 | 2,600 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $1,297,100 | 1,700 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $1,559,060 | 2,000 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $1,651,820 | 2,000 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $308,800 | 400 | Shares | Defined | 2025-01-17 | |
| 2024-09-30 | $1,594,692 | 1,800 | Shares | Defined | 2024-10-18 | |
| 2024-06-30 | $3,621,520 | 4,000 | Shares | Defined | 2024-07-26 | |
| 2024-03-31 | $3,111,840 | 4,000 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $1,340,716 | 2,300 | Shares | Defined | 2024-02-08 | |
| No filing history on record for this holder in this stock. | ||||||